BCL6 and B-cell non-Hodgkin lymphoma: Activation of CD40 receptors in B cell lymphoma leads to NF-κB- mediated IRF4 transcription factor induction, which represses Bcl-6 expression by binding to the Bcl-6 promoter [77].